Abstract: The invention relates to a perforating device for thermoplastic plates, which relates to the technical field of a plate processing device. The device comprises an electromagnetic chuck, one side of the electromagnetic chuck is connected with the motion part, the other side of the electromagnetic chuck is connected with a mounting plate and a spike. When the electromagnetic chuck is powered on, the spike is attracted below the mounting plate by the electromagnetic force. A clamping part is arranged below the mounting plate, the thermoplastic plate is fixed by the clamping part, and a heating system is also provided to heat the thermoplastic plate. As the electromagnetic chuck is powered on or off, the spike can be attracted in or separated from the mounting plate, respectively. Therefore, the perforating device can make a new plate be pierced during the cooling and curing process of the perforated plate.

Abstract: Disclosed is a multi-layer low-profile four-arm spiral antenna, including a metal grounding plate, and a top surface of the metal grounding plate is fixedly connected with three layers of cylindrical dielectric substrates; the three layers of dielectric substrates are coaxially arranged, and the three layers of dielectric substrates are coaxially arranged with the metal grounding plate, and a gap is set between two adjacent layers of dielectric substrates; four spiral metal strips with a same rotation direction are respectively arranged on each layer of dielectric substrate, the four spiral metal strips on each layer of dielectric substrate form spiral radial arms, and a phase difference of the four spiral metal strips on each layer of dielectric substrate is 90°; the corresponding spiral metal strips on the two adjacent layers of dielectric substrates are connected by connecting bridges, the connecting bridges are arranged in the gap.

Abstract: The present invention relates to an apparatus for automatically charging a vehicle in an unmanned intelligent parking device, which is applied to various unmanned parking devices in need of a charging function. The apparatus includes a carrier fora parking device, the carrier being provided with a lifting component and a traveling component, where the apparatus further includes a charging docking apparatus, a charging adapter, a storage location charging fixing seat and a storage location power pickup apparatus, the storage location charging fixing seat is arranged in a parking space of the parking device, the carrier is provided with the charging docking apparatus, the storage location power pickup apparatus is mounted on the storage location charging fixing seat, and the charging adapter is switched to the storage location charging fixing seat through the charging docking apparatus and electrically connected to the storage location power pickup apparatus.

Abstract: The present disclosure is directed to a cable securement assembly for protecting cables and/or cable bundles within a wind turbine. The cable securement assembly includes a cable spacer having an inner surface and an outer surface separated by a thickness and one or more fastening components. The inner surface defines an open center configured to receive the plurality of cables therein. The inner surface defines a plurality of cable locations defined by one or more through holes configured through the thickness. The one or more fastening components are configured to secure one or more of the plurality of cables at each cable location via the through holes.

Abstract: The present disclosure is directed to a cable securement assembly for protecting cables and/or cable bundles within a wind turbine. The cable securement assembly includes a cable spacer having an inner surface and an outer surface separated by a thickness and one or more fastening components. The inner surface defines an open center configured to receive the plurality of cables therein. The inner surface defines a plurality of cable locations defined by one or more through holes configured through the thickness. The one or more fastening components are configured to secure one or more of the plurality of cables at each cable location via the through holes.

Abstract: A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-?-hydroxysteroid dehydrogenase Type 1 enzyme activity.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: The present invention relates to inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-?-hydroxysteroid dehydrogenase Type 1 enzyme activity.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-?-hydroxysteroid dehydrogenase Type 1 enzyme activity.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: The present invention relates to inhibitors of 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-?-hydroxysteroid dehydrogenase Type 1 enzyme activity.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.

Abstract: The present invention relates to inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their use in treatment of non-insulin dependent type 2 diabetes, insulin resistance, obesity, lipid disorders, metabolic syndrome, central nervous system disorders, and diseases and conditions that are related to excessive glucocorticoids.